top of page


A world-class team of experts with experience in developing antibody therapeutics.

  • MIT, Post Doc Associate

  • Texas A&M University, Ph.D.

Yong In Kim Ph.D.   CEO & Founder

  • Abbott  (AbbVie) (Worcester, USA) Senior scientist, Assay group leader

    • R&D of the mega-blockbuster antibody drug, HUMIRA , and leading several therapeutic antibody programs

  • Novartis, NIBR (Cambridge, USA) Lab Head, Team leader

    • Leading several therapeutic antibody programs for age-related macular degeneration

  • Samsung Advanced Institute of Technology  VP, Biotherapeutics

    • Infrastructure establishment for antibody technology for the bio-pharma business

    • Development of antibody drug candidates ABTAA* and establishing ADC portfolio

  • Medytox, Inc Senior VP, New business development

    • R&D of the innovative drugs such as Oral biologics, Immuno-oncology antibodies and Microbiome therapeutics

bottom of page